Track record · closed signal

Morgan Stanley (MS) — closed signal from October 20, 2025

Target reached Published before the outcome was known, scored automatically when the window closed on January 18, 2026.

Predicted vs. what happened

MS price · publication thesis → realized outcomesplit-adjusted
$160.59 Published $185.15 Target $189.09 Window close $192.68 Peak
$156.59 – $161.03Entry zone — fair-value band
$160.59Published — price the day we called it
$185.15Target — the price the thesis aimed for
$192.68Peak — highest point inside the window, not a realized return
$189.09Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 77 days.

Peak price
$192.68
peak on January 16, 2026 — not a realized return
Peak gain
+20%
peak, from the publication price
Window close
$189.09
end-of-window price, context only
Days to target
77
Window
October 20, 2025 – January 18, 2026

The thesis — published October 20, 2025

Predicted growth
+16%
over the measurement window
Target price
$185.15
the price the thesis aimed for
Entry zone
$156.59 – $161.03
the fair-value band we waited for
Price at publication
$160.59
published October 20, 2025
Confidence
69%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Morgan Stanley could benefit as company profits across the market are expected to rise about 8.5% in Q3, which supports steady wealth management and banking activity. Investor mood is upbeat, and the price trend looks healthier, with the recent average price improving. For the next 1-3 months, a gradual climb is likely as more investors take risk, lots more people are buying than usual, and trading interest returns.

Primary drivers

  • Stronger profit outlook supports steady wealth and banking activity in the near term
  • Upbeat mood and healthier price trend, with recent average price improving
  • Large, stable wealth business offers dependable fees and cross-selling
  • Buying in stages matches a patient plan for a steady climb over weeks

How it played out

MS: target reached in 77 days

On 2025-10-20, Lyra published a short-term MS thesis at $160.59. It expected 16% growth toward $185.15. The thesis pointed to a stronger profit outlook, steady wealth and banking activity, upbeat investor mood, a healthier price trend, a large wealth business, and buying in stages for a patient climb over weeks.

Inside the window, MS reached the target. The peak was $192.68 on 2026-01-16, with a 20% gain, and the target was reached in 77 days. The window ended at $189.09. The published thesis played out.

What happened during the window

On 2025-10-29, Morgan Stanley agreed to buy EquityZen, a platform for trading shares of private companies. On 2026-01-15, Financial News reported Morgan Stanley's fourth-quarter investment banking net revenue rose 47% to $2.4 billion.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All MS signals